Skip to main content
SpringerLink
Log in

CD44H is Expressed by cells of the Oligodendrocyte Lineage and by Oligodendrogliomas in Humans

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

CD44, a family of cell surface glycoproteins involved in cell–cell and cell–extracellular matrix adhesion, is widely expressed in the white matter of the normal brain and in astrocytic gliomas under its standard form (CD44s also called CD44H). On the other hand, several variants have been found in brain metastases and rarely found in gliomas. We have investigated by immunohistochemistry CD44H and CD44v6 expression in 28 oligodendrogliomas. All tumors were CD44v6 negative whereas nearly all tumors were immunolabelled with anti-CD44H antibody. Immunostaining increased in parallel with grade and was particulary strong around vessels and in tumoral subpial nodules. Western blot analysis showed that oligodendrogliomas expressed the same 80-kDa CD44 isoform as normal brain.

Since gliomas may arise from a dividing progenitor cell, we also studied CD44H expression during the oligodendrocyte lineage in vitro in parallel with specific markers of the O-2A cells. Precursor cells (PSA–NCAM positive), O-2A progenitor cells, as well as preoligodendrocytes (A2B5 positive cells) and immature oligodendrocytes (O4 positive cells), coexpressed CD44H.

Our data showed that CD44H is expressed by cells of the oligodendrocyte lineage in vitro and by oligodendrogliomas in vivo especially in sites of dissemination such as subpial spaces. This suggests that CD44H could play a role in migration of tumor cells in oligodendrocytic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Picker JP, De Los Toyos J, Telen MJ, Haynes BF, Butcher EC: Monoclonal antibodies against the CD44 (In(Lu)-related p80), and Pgp-1 antigens in man recognize the hermes class of lymphocyte homing receptors. J Immunol 6: 2046–2051, 1989

    Google Scholar 

  2. Picker LJ, Nakache M, Butcher EC: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109: 927–937, 1989

    Google Scholar 

  3. Goodison S, Urquidi V, Tarin D: CD44 cell adhesion molecules. J Clin Pathol Mol Pathol 52: 189–196, 1999

    Google Scholar 

  4. Kincade PW, Zheng Z, Katoh S, Hanson L: The importance of cellular environment to function of the CD44 matrix receptor. Cur Opin Cell Biol 9: 635–642, 1997

    Google Scholar 

  5. Shoshan Y, Nishiyama A, Chang A, Mörk S, Barnett GH, Cowell JK, Trapp D, Stangaitis SM: Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci 96: 10361–10366, 1999

    Google Scholar 

  6. Asher R, Bignami A: Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes. Exp Cell Res 203: 80–90, 1992

    Google Scholar 

  7. Girgrah N, Letarte M, Becker LE, Cruz TF, Theriault E, Moscarello MA: Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis. J Neuropathol Exp Neurol 50: 779–792, 1991

    Google Scholar 

  8. Kaaijk P, Pals ST, Morsink F, Bosch DA, Troost D: Differential expression of CD44 splice variants in the normal human central nervous system. J Neuroimmunol 73: 70–76, 1997

    Google Scholar 

  9. Pilkington GJ: Tumor cell migration in the central nervous system. Brain Pathol 4: 157–166, 1994

    Google Scholar 

  10. Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Greissard P: Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumor stroma. Eur J Cancer 7: 1012–1017, 1993

    Google Scholar 

  11. Philipson LH, Schwartz NB: Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J Biol Chem 25: 5017–5023, 1984

    Google Scholar 

  12. Ariza A, Lopez D, Mate JL et al.: Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26: 1144–1147, 1995

    Google Scholar 

  13. Baltuch GH, De Tribolet N, Van Meir EG: Expression of the CD44adhesion molecule in tumors of the central and peripheral nervous system. J Neuro-Oncol 26: 191–198, 1995

    Google Scholar 

  14. Kuppner MC, Van Meir E, Gauthier Th, Hamou MF, De Tribolet N: Differential expression of the CD44 molecule in human brain tumors. Int J Cancer 50: 572–577, 1992

    Google Scholar 

  15. Tanabe KK, Saya H: The CD44 adhesion molecule and metastasis. Crit Rev Oncogenesis 5: 201–212, 1994

    Google Scholar 

  16. Bouterfa H, Janka M, Meese E, Kerkau S, Roosen K, Tonn JC: Effect of changes in the CD44 gene on tumor cell invasion in gliomas. Neuropathol Applied Neurobiol 23: 373–379, 1997

    Google Scholar 

  17. Goldbrunner RH, Bernstein JJ, Tonn JC: Cell-extracellular matrix interactions in glioma invasion. Acta Neurochir (Wien) 141: 295–305, 1999

    Google Scholar 

  18. Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M: Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 66: 255–260, 1996

    Google Scholar 

  19. Pilkington GJ, Akinwunmi J, Ognjenovic N, Rogers JP: Differential binding of anti-CD44 on human gliomas in vitro. Clin Neurosc Neuropathol 4: 259–262, 1993

    Google Scholar 

  20. Radotra B, McCormick D: Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J Pathol 181: 434–438, 1997

    Google Scholar 

  21. Koochekpour S, Pilkington GJ, Merzak A: Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 63: 450–454, 1995

    Google Scholar 

  22. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS: Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82: 858–863, 1995

    Google Scholar 

  23. Frank S, Rihs HP, Stöcker W, Muller J, Dumont B, Baur X, Schackert HK, Schackert G: Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Biochem Biophys Res Comm 222: 794–801, 1996

    Google Scholar 

  24. Eibl RH, Pietsch T, Moll J, Skroch-Angel P, Heinz Heider K, Von Amon K, Wiestler O, Ponta H, Kleihues P, Herrlich P: Expression of variant CD44 epitopes in human astrocytic brain tumors. J Neuro-Oncol 26: 165–170, 1995

    Google Scholar 

  25. Kaaijk P, Troost D, Morsink F, Keehnen R, Leenstra S, Bosch DA, Pals ST: Expression of CD44 splice variants in human primary brain tumors. J Neuro-Oncol 26: 185–190, 1995

    Google Scholar 

  26. Hagel C, Stavrou DK: CD44: expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue. Neuropathol Appl Neurobiol 25: 313–318, 1999

    Google Scholar 

  27. Deloume JC, Laeng P, Janet T, Sensenbrenner M, Baudier J: Expression of neuromodulin (GAP43) and its regulation by b-FGF during the differenciation of O-2A progenitor cells. J Neurosci Res 36: 147–162, 1993

    Google Scholar 

  28. Shi S, Key M, Kalra K: Antigen retrieval in formalin fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741–748, 1991

    Google Scholar 

  29. Rougon G, Dubois C, Buckley N, Magnani JL, Zollinger WA: Monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult NCAM. J Cell Biol 103: 2429–2467, 1986

    Google Scholar 

  30. Dubois C, Manuguerra JC, Hauttecoeur B, Maze J: Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (Neu AC) 3 lacCer) and to its 9-O-acetylated derivative. J Biol Chem 265(5): 2797–2803, 1990

    Google Scholar 

  31. Figarella-Branger D, Moreau H, Pellissier JF, Bianco N, Rougon G: CD24, a signal-transducing molecule expressed on humanBlymphocytes is a marker for human regenerating muscle. Acta Neuropathol 186: 275–284, 1993

    Google Scholar 

  32. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132: 1199–1208, 1996

    Google Scholar 

  33. Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunol 93: 139–148, 1998

    Google Scholar 

  34. Catterall JB, Jones LMH, Turner GA: Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metast 17: 583–591, 1999

    Google Scholar 

  35. Sheng Y, Yoshimura M, Inoue S, Oritani K, Nishiura T, Yoshida H, Ogawa M, Okajima Y, Matsuzawa Y, Taniguchi N: Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing â1,4 Nacetylglucosaminyltransferase III. Int J Cancer 73: 850–858, 1997

    Google Scholar 

  36. Nakamura Y, Yamamoto M, Itoh S, Haratake A, Nakano Y, Hashimoto T: Growth factors in infant germinal matrix: relationship to extracellular matrix and cell adhesion molecules. J Neuropathol Exp Neurol 57: 858–865, 1998

    Google Scholar 

  37. Daniel L, Lechevallier E, Roch G, Lindner V, DeFromont M, Viellefond A, Coulange C, Figarella-Branger D: CD44s and CD44V6 expression in localized T1-T2 conventional renal cell carcinoma. J Pathol 193: 345–349, 2001

    Google Scholar 

  38. Ylagan LR, Quinn B: CD44 Expression in astrocytic tumors. Mod Pathol 10: 1239–1246, 1997

    Google Scholar 

  39. Radotra B, Cormick D: CD44 Involved in migration but not spreading of astrocytoma cells in vitro. Anti-Cancer Res 17: 945–950, 1997

    Google Scholar 

  40. Figarella-Branger D, Daniel L, André P, Guia S, Renaud W, Monti G, Vivier E, Rougon G: The Pen5 epitope identifies an oligodendrocyte recursor cell population and pilocytic astrocytomas. Am J Pathol 155: 1261–1269, 1999

    Google Scholar 

  41. Moretto G, Xu RY, Kim SU: CD44 Expression in human astrocytes and oligodendrocytes in culture. J Neuropathol Exp Neurol 52: 419–423, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuromuscular Biopathology, Faculty of Medicine Timone, Marseille, CNRS, Parc Scientifique de Luminy, Marseille, France

    Corinne Bouvier-Labit, Agnès Liprandi, Jean Francçois Pellissier & Dominique Figarella-Branger

  2. Department of Genetics and Developmental Physiology, CNRS, Parc Scientifique de Luminy, Marseille, France

    Gilberte Monti

Authors
  1. Corinne Bouvier-Labit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agnès Liprandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gilberte Monti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Francçois Pellissier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dominique Figarella-Branger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bouvier-Labit, C., Liprandi, A., Monti, G. et al. CD44H is Expressed by cells of the Oligodendrocyte Lineage and by Oligodendrogliomas in Humans. J Neurooncol 60, 127–134 (2002). https://doi.org/10.1023/A:1020630732625

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020630732625

Search

Navigation